These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 24675460

  • 21. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
    Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ.
    Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
    [Abstract] [Full Text] [Related]

  • 22. Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation.
    De Ketelaere A, Vermeulen L, Vialard J, Van De Weyer I, Van Wauwe J, Haegeman G, Moelans I.
    FEBS Lett; 2004 May 21; 566(1-3):60-4. PubMed ID: 15147869
    [Abstract] [Full Text] [Related]

  • 23. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y, Harashima N, Tajima Y, Harada M.
    Oncotarget; 2015 Dec 08; 6(39):41902-15. PubMed ID: 26506422
    [Abstract] [Full Text] [Related]

  • 24. 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells.
    Yadav VR, Prasad S, Gupta SC, Sung B, Phatak SS, Zhang S, Aggarwal BB.
    J Biol Chem; 2012 Jan 02; 287(1):245-256. PubMed ID: 22065587
    [Abstract] [Full Text] [Related]

  • 25. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 26. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 27. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
    Liu Q, Mier JW, Panka DJ.
    Mol Cancer; 2011 Sep 19; 10():115. PubMed ID: 21929745
    [Abstract] [Full Text] [Related]

  • 28. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
    Wilson W, Baldwin AS.
    Cancer Res; 2008 Oct 01; 68(19):8156-63. PubMed ID: 18829575
    [Abstract] [Full Text] [Related]

  • 29. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gélinas C, Fuchs EJ, Bedi A.
    Nat Cell Biol; 2001 Apr 01; 3(4):409-16. PubMed ID: 11283615
    [Abstract] [Full Text] [Related]

  • 30. GSK-3 represses growth factor-inducible genes by inhibiting NF-kappaB in quiescent cells.
    Graham JR, Tullai JW, Cooper GM.
    J Biol Chem; 2010 Feb 12; 285(7):4472-80. PubMed ID: 20018891
    [Abstract] [Full Text] [Related]

  • 31. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.
    Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754
    [Abstract] [Full Text] [Related]

  • 32. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
    Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB.
    Mol Cell Biol; 2003 Jul 19; 23(13):4649-62. PubMed ID: 12808104
    [Abstract] [Full Text] [Related]

  • 33. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC.
    J Pharmacol Exp Ther; 2007 May 19; 321(2):616-25. PubMed ID: 17289836
    [Abstract] [Full Text] [Related]

  • 34. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL, Xie XB, Wang J, Chen Q, Han AJ, Zou CY, Yin JQ, Liu DW, Liang Y, Zhao ZQ, Yong BC, Zhang RH, Feng QS, Deng WG, Zhu XF, Zhou BP, Zeng YX, Shen JN, Kang T.
    J Natl Cancer Inst; 2012 May 16; 104(10):749-63. PubMed ID: 22534782
    [Abstract] [Full Text] [Related]

  • 35. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
    Hu Y, Gu X, Li R, Luo Q, Xu Y.
    J Exp Clin Cancer Res; 2010 Nov 26; 29(1):154. PubMed ID: 21110852
    [Abstract] [Full Text] [Related]

  • 36. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
    Kunnumakkara AB, Ichikawa H, Anand P, Mohankumar CJ, Hema PS, Nair MS, Aggarwal BB.
    Mol Cancer Ther; 2008 Oct 26; 7(10):3306-17. PubMed ID: 18852134
    [Abstract] [Full Text] [Related]

  • 37. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.
    Schwabe RF, Brenner DA.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul 26; 283(1):G204-11. PubMed ID: 12065308
    [Abstract] [Full Text] [Related]

  • 38. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ, Stang MT, Liu Y, Yan J, Pizzoferrato E, Yim JH.
    Cancer Biol Ther; 2015 Jul 26; 16(7):1029-41. PubMed ID: 26011589
    [Abstract] [Full Text] [Related]

  • 39. NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.
    Casanelles E, Gozzelino R, Marqués-Fernández F, Iglesias-Guimarais V, Garcia-Belinchón M, Sánchez-Osuna M, Solé C, Moubarak RS, Comella JX, Yuste VJ.
    Biochim Biophys Acta; 2013 May 26; 1833(5):1085-95. PubMed ID: 23369735
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.
    Dai C, Wen X, He W, Liu Y.
    J Biol Chem; 2011 Mar 04; 286(9):7052-9. PubMed ID: 21189258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.